J-Pharma Inc.
Basic information
- Head office
- 8th Floor, VORT Hamamatsucho II, 1-10-11 Hamamatsucho, Minato-ku, Tokyo 105-0013, Japan
- Chief executive
- Masahiro Yoshitake
- Capital
- 2,033,000,000 (20 100 million)
- Employees (non-consolidated)
- 18 people
- Employees (consolidated)
- 18 people
- Start date
- 2005-12-26
- End date
Websites
Business
Related companies
—
Network
History
Established J-Pharma Inc. as a company specializing in drug development targeting cell membrane transporters in Toranomon 1-chome, Minato-ku, Tokyo.![]()
Founded J-Pharma Inc. in Toranomon 1-chome, Minato-ku, Tokyo, as a company specializing in drug development targeting cell membrane transporters![]()
Supported the development of a hyperphosphatemia treatment drug through the Pharmaceutical Infrastructure Research Institute's project for practical application of pharmaceuticals and medical devices.![]()
Supported the development of a gastric cancer therapy through NEDO's innovation commercialization support project.![]()
Supported the development of a novel molecular probe targeting cancer cell-specific membrane proteins through the Ministry of Education, Culture, Sports, Science and Technology's molecular imaging research program.![]()
Supported the research and development of a new phosphate adsorbent JPH101 and Phase 1 clinical trials through NEDO's innovation promotion project.![]()
Established Tajima CPA Office in 2010, providing management and funding support mainly for biotech ventures.![]()
Supported the development of a new anti-cancer therapy targeting the essential amino acid transporter LAT1 expressed in cancer cells, bridging basic and clinical research.![]()
Supported the clinical development of an innovative anti-cancer drug by inhibiting amino acid transporters through NEDO's venture commercialization support project.![]()
Supported the development of an in vitro diagnostic kit for triple-negative malignant breast cancer through Yokohama City special zone leading project grant.![]()
Supported the clinical trial of a new anti-cancer drug JPH203 to secure proof of concept (POC) through NEDO's venture commercialization support project.![]()
Supported the commercialization of an in vitro diagnostic for triple-negative breast cancer through Yokohama City special zone leading project grant.![]()
Signed license and joint development agreement with Ohara Pharmaceutical Co., Ltd. regarding Namburanlat![]()
Signed license and joint development agreement with Ohara Pharmaceutical Co., Ltd. regarding Namburanlat![]()
Namburanlat designated as an orphan drug (rare disease drug) by the U.S. Food and Drug Administration (FDA)![]()
Namburanlat designated as an orphan drug (rare disease drug) by the U.S. Food and Drug Administration (FDA)![]()
Development of central nervous system-penetrant LAT1 inhibitor (development code: JPH034) for multiple sclerosis was adopted by the U.S. National Multiple Sclerosis Society (NMSS) Fast Forward commercialization research grant program and received funding![]()
Established J-Pharma USA to recruit personnel for drug development in the U.S. (liquidated in July 2025)![]()
JPH034 was adopted by the Japan Agency for Medical Research and Development (AMED) 'Drug Discovery Venture Ecosystem Enhancement Project'![]()
IND application for clinical trials of Namburanlat in cancer patients approved by the U.S. Food and Drug Administration (FDA)![]()
IND application for clinical trials of Namburanlat in cancer patients approved by the U.S. Food and Drug Administration (FDA)![]()
Received positive response from the U.S. FDA regarding CMC (Chemistry, Manufacturing, and Controls) of Namburanlat, confirming compliance with quality standards required for commercial manufacturing in the U.S.![]()
News
There is no news.
Public records
National Tax Agency basic information6011101043476
- Trade name
- ジェイファーマ株式会社
- Trade name (kana)
- ジェイファーマ
- Name in English
- Corporation type
- 301
- Address
- 〒105-0013 東京都港区浜松町1丁目10番11号
- Postal code
- 1050013
- Prefecture code
- 13
- City code
- 103
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2025-07-09
- Change date
- 2025-07-04
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 12
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 2099647
METI gBizINFO6011101043476
- Corporate number
- 6011101043476
- Trade name
- ジェイファーマ株式会社
- Trade name (kana)
- ジェイファーマ
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都港区浜松町1丁目10番11号
- Postal code
- 1050013
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 港区
- City code
- 103
- Street address
- 浜松町1丁目10番11号
- Organisation type
- 301
- Processing type
- 12
- Correction type
- 0
- Status
- Representative
- 代表取締役社長 吉武 益広
- Capital
- 2032697000
- Employees
- 16
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2025-07-09
- Key information
- 6011101043476